What Is a Biochemical Pregnancy?

A biochemical pregnancy is a very early pregnancy loss that happens shortly after an embryo implants in the uterine wall but before it can be seen on ultrasound. The pregnancy is confirmed only by a brief, low-level rise in hCG (the hormone detected by pregnancy tests) that soon falls back to zero. Many people experience a positive test followed by bleeding around the time of an expected period and never realize the distinction between a biochemical pregnancy and a late period. The biology behind these losses, though, is more layered than it first appears, involving everything from embryo genetics to uterine timing to factors on the sperm side that rarely get discussed.

What Makes a Pregnancy “Biochemical”

The term refers to a pregnancy that is detectable only through biochemistry, meaning blood or urine hCG levels, and never reaches the clinical stage where a gestational sac appears on ultrasound. That ultrasound milestone typically happens around five to six weeks of gestation. If hCG rises enough to produce a positive test but the pregnancy stops developing before that point, it falls into the biochemical category. In fertility clinics, this distinction matters because it separates pregnancies that showed some implantation activity from cycles where no implantation occurred at all.

In everyday life, someone who is not actively tracking fertility may experience a biochemical pregnancy as a period that arrives a few days late and is slightly heavier than usual. The pregnancy is so brief that before the era of sensitive home tests, most would never have known about it.

How hCG Levels Predict the Outcome

The initial hCG level after embryo transfer or around the time of a missed period gives doctors a rough sense of where things are headed. In one study of single embryo transfers, when the first blood hCG measurement fell in the range of roughly 74 to 135, half of those pregnancies ended as biochemical losses. Once hCG climbed above about 200, the rate of biochemical loss dropped to around 12 percent.

When a biochemical pregnancy does end, hCG levels drop on their own without medical intervention. The rate of decline depends on how high the hormone reached in the first place: higher starting values are associated with a steeper drop. Research on spontaneous complete abortion found that hCG declined by roughly 21 to 35 percent over two days and 60 to 84 percent over a week, depending on the initial concentration.¹ In clinical practice, hCG is usually monitored until it falls below about 5 to 20 IU/L, confirming the pregnancy has resolved.²

One diagnostic wrinkle worth knowing about: when hCG is rising or falling slowly and no pregnancy is visible on ultrasound, the situation may be classified as a “pregnancy of unknown location.” That label can include a failing intrauterine pregnancy, but it can also include an ectopic pregnancy, which is why doctors sometimes order repeat blood draws and imaging rather than simply labeling it a biochemical loss right away.³

How Common Biochemical Pregnancies Are

Biochemical pregnancies are surprisingly common, and a large share go entirely unnoticed. Among women undergoing IVF, biochemical loss rates are well documented because blood hCG testing is routine. One large comparative study found a biochemical pregnancy rate of about 14 percent in IVF cycles, which was actually lower than the roughly 18 percent rate observed in naturally conceiving fertile women. The researchers suggested that the ability to select embryos for transfer may explain the lower rate in IVF.⁴ That finding pushes back against the common assumption that IVF pregnancies are inherently more fragile in the earliest days.

Among IVF cycles that include preimplantation genetic testing for chromosomal abnormalities, the biochemical loss rate has been reported at around 18 percent of those that implanted.⁵ The fact that even chromosomally screened embryos still produce biochemical losses at that rate underscores that embryo genetics is not the whole story.

Why Biochemical Pregnancies Happen

There is rarely a single culprit. Biochemical losses sit at the intersection of embryo quality, uterine receptivity, hormonal environment, and immune factors, and most of the time no definitive cause is identified for any individual episode.

Embryo Chromosomal Problems

The most frequent driver of very early pregnancy loss is an abnormal number of chromosomes in the embryo. Chromosomal errors arise randomly during egg or sperm cell division and become more common as parental age increases. When IVF clinics test embryos before transfer, transferring only embryos with the correct chromosome count does reduce early miscarriage. A large retrospective study found that transferring chromosomally normal (euploid) embryos lowered the odds of early miscarriage by about 25 percent compared with transferring untested embryos.⁶ Interestingly, the same study found that the visual grading of an embryo’s appearance under the microscope was not a reliable predictor of biochemical pregnancy or early miscarriage, which means a “perfect-looking” embryo can still carry chromosomal problems that grading cannot detect.

Uterine Timing and Receptivity

Even a chromosomally normal embryo needs to arrive in the uterus during a narrow time frame when the endometrial lining is receptive. Research using gene-expression profiling of the endometrium has shown that the window of implantation varies from person to person. In one study, women whose endometrial profile corresponded to optimal receptivity had a biochemical pregnancy rate of about 7 percent. But women whose profiles indicated a late receptive stage had a biochemical rate of 50 percent, and their ongoing pregnancy rates dropped from around 80 percent to 33 percent.⁷

A separate study confirmed these findings in practice: embryo transfers that deviated from the personalized implantation window showed roughly double the pregnancy loss rate compared with transfers timed to that window.⁸ This is one of the clearer examples of a modifiable factor: if endometrial timing is off, adjusting the transfer day can meaningfully reduce the chance of a biochemical loss.

Hormonal Environment

Progesterone is the hormone that maintains the uterine lining after implantation, and low progesterone has consistently been linked to first-trimester miscarriage.⁹ The relationship is not as simple as “more progesterone equals better,” though. In IVF cycles, excessively high progesterone on the day of embryo transfer has also been associated with worse outcomes. One study found that when progesterone exceeded 20 ng/mL on the day of transfer, biochemical and missed abortion rates were more than double those seen at lower levels. As progesterone climbed further, live birth rates trended downward in a dose-dependent fashion.¹⁰

Beyond progesterone, other hormonal conditions can play a role. Thyroid dysfunction, polycystic ovarian syndrome, poorly controlled diabetes, and elevated prolactin have all been associated with recurrent pregnancy loss.¹¹ Many of these are treatable, which is why workups for recurrent loss routinely include thyroid panels and blood sugar testing.

Immune Factors at the Implantation Site

The uterine lining contains a specialized population of immune cells, including natural killer cells that behave quite differently from those circulating in the blood. Emerging research suggests these uterine natural killer cells play a gatekeeping role: they help clear away aging cells in the lining and may participate in selecting which embryos survive the earliest days of implantation. Laboratory experiments have shown that failing embryos actually suppress this clearing mechanism, while embryos destined for successful implantation do not.¹² The immunology of early pregnancy is still being worked out, and there are currently no validated immune-based treatments that reliably prevent biochemical loss.

Sperm Quality and Biochemical Pregnancy

Conversations about early pregnancy loss tend to focus on the egg and the uterus, but sperm quality contributes too. The relevant measure here is not the standard semen analysis (count, motility, shape) but rather the integrity of the DNA inside the sperm cell. High levels of sperm DNA fragmentation have been linked to both biochemical pregnancy and early clinical miscarriage.

A systematic review and meta-analysis of IVF and ICSI outcomes found that sperm DNA damage roughly doubled the odds of pregnancy loss, with a combined odds ratio of about 2.5.¹³ The association was particularly strong in ICSI cycles, where a single sperm is injected directly into the egg, bypassing some of the natural selection that occurs during standard fertilization. In those cases, clinical pregnancy rates and pregnancy loss rates both differed significantly between men with high versus low DNA fragmentation.¹⁴

More recent work using a sensitive technique called the comet assay found that male partners of women who had miscarried had sperm DNA damage scores roughly double those of fertile men, and the test was highly accurate at distinguishing between the two groups.¹⁵ Sperm DNA fragmentation testing is not yet routine, but these findings are building a case that it should be part of the evaluation when couples experience repeated early losses.

Environmental Exposures Worth Knowing About

Bisphenol A (BPA), a chemical found in certain plastics and can linings, has drawn attention as a potential contributor to early pregnancy loss. A study measuring conjugated BPA in maternal blood found that women in the highest quartile of exposure had roughly 1.8 times the risk of miscarriage compared with women in the lowest quartile, and the increased risk applied to both chromosomally normal and abnormal losses.¹⁶ This is a single observational study, so it cannot prove causation, but BPA is one of the more studied endocrine disruptors in the context of reproductive health. Practical steps like avoiding heating food in plastic containers and choosing BPA-free products are low-cost precautions, though the evidence base is not yet strong enough for formal clinical guidelines on this front.

What a Biochemical Pregnancy Means for Your Next Cycle

One of the most important things to understand is that a biochemical pregnancy is not a bad prognostic sign for future fertility. In fact, it may be a mildly encouraging one. A study tracking IVF outcomes across multiple cycles found that women whose first cycle ended in a biochemical pregnancy had a subsequent ongoing clinical pregnancy rate of about 38 percent, compared with 27 percent for women whose first cycle produced a completely negative pregnancy test. The cumulative pregnancy rate after that first attempt was 54 percent in the biochemical pregnancy group versus about 47 percent in the negative-test group.¹⁷ The logic is that a biochemical pregnancy at least demonstrates the ability to implant, which is a hurdle many embryos never clear.

That said, recurrent biochemical pregnancies may warrant closer investigation. A large cohort study of over 10,000 IVF cases found that women who had a biochemical pregnancy in their first cycle were more likely to have another one in subsequent cycles, with a biochemical rate of about 8 percent compared with 4 percent in women who had a negative first cycle.¹⁸ Clinical pregnancy rates in the next cycle were similar across groups, so a prior biochemical loss did not reduce the overall chance of eventually achieving a clinical pregnancy, but the tendency to repeat suggests some underlying factor, whether uterine, hormonal, or immunological, that could potentially be identified and addressed.

The Emotional Side

Biochemical pregnancies occupy an awkward space. They are early enough that some people dismiss them as “not really a pregnancy,” yet the person who saw that positive test experienced the hope and then the loss. Research on recurrent pregnancy loss broadly has found that depression and high stress levels are substantially more common in this population. One study found that women with recurrent loss were more than five times as likely to score in the moderate-to-severe range for depression compared with pregnant women without a history of loss, and about 41 percent of recurrent-loss patients reported high stress levels versus 23 percent in the comparison group.¹⁹

The grief after a biochemical pregnancy often goes unacknowledged by friends, family, and sometimes even medical providers, partly because the loss is so early and partly because it can be invisible to anyone who was not told about the positive test. If you have experienced one, the emotional response is real and valid regardless of gestational age.

Uterine Shape and Early Loss Patterns

An unexpected finding from research on uterine structural differences complicates the intuition that anatomical abnormalities would cause more biochemical losses. Women with a septate, bicornuate, or arcuate uterus who had recurrent miscarriages actually showed significantly fewer biochemical losses than controls, with rates around 9 to 11 percent compared with 30 percent in women with normal uterine anatomy.²⁰ Their pregnancies were more likely to fail at a later gestational age instead. The researchers interpreted this to mean that uterine structural problems do not impair the very earliest stage of implantation so much as they compromise the pregnancy once it grows and places greater physical demands on the uterine cavity. For someone with a known uterine anomaly, this distinction matters: the risk period is not the same as for someone whose losses cluster in the biochemical window.